Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression

BACKGROUND: In an 8-week, randomized, placebo-controlled, double-blind study, an extended-release formulation of quetiapine, quetiapine XR, demonstrated efficacy and safety in Japanese patients with bipolar depression. Bipolar disorder is a chronic disease requiring continuous treatment. METHODS: Th...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Psychiatry
Päätekijät: Kanba, Shigenobu, Murasaki, Mitsukuni, Koyama, Tsukasa, Takeuchi, Masahiro, Shimizu, Yuriko, Arita, Eri, Kuroishi, Kentaro, Kamei, Shinya
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2019
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6595609/
https://ncbi.nlm.nih.gov/pubmed/31242884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-019-2181-9
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia